Pacific Biosciences (PACB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2023 | 09-2023 | 06-2023 | 03-2023 | 12-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -306,735 | -224,717 | -157,848 | -88,015 | -314,248 |
| Depreciation Amortization | 13,694 | 4,747 | 3,267 | 2,361 | 17,074 |
| Income taxes - deferred | -11,424 | -10,706 | N/A | N/A | N/A |
| Accounts receivable | -17,829 | -11,700 | -5,248 | -10,803 | 5,455 |
| Accounts payable and accrued liabilities | 206 | 1,706 | 4,262 | 5,068 | 1,025 |
| Other Working Capital | -58,957 | -51,217 | -38,622 | -43,129 | -53,972 |
| Other Operating Activity | 121,872 | 90,274 | 57,757 | 39,827 | 81,455 |
| Operating Cash Flow | $-259,173 | $-201,613 | $-136,432 | $-94,691 | $-263,211 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 13,549 | 78,100 | -165,155 | -68,832 | 133,012 |
| PPE Investments | -8,843 | -6,819 | -5,989 | -3,721 | -16,750 |
| Net Acquisitions | -102 | -102 | N/A | N/A | N/A |
| Purchase Sale Intangibles | N/A | N/A | N/A | N/A | -179 |
| Other Investing Activity | 0 | 0 | 0 | 0 | -179 |
| Investing Cash Flow | $4,604 | $71,179 | $-171,144 | $-72,553 | $116,083 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -1,842 | -1,397 | -911 | -446 | -1,608 |
| Common Stock Issued | 204,519 | 203,583 | 199,021 | 196,435 | 11,230 |
| Other Financing Activity | -93,786 | -11,693 | -6,836 | 0 | 0 |
| Financing Cash Flow | $108,891 | $190,493 | $191,274 | $195,989 | $9,622 |
| Beginning Cash Position | 328,311 | 328,311 | 328,311 | 328,311 | 465,817 |
| End Cash Position | 182,633 | 388,370 | 212,009 | 357,056 | 328,311 |
| Net Cash Flow | $-145,678 | $60,059 | $-116,302 | $28,745 | $-137,506 |
| Free Cash Flow | |||||
| Operating Cash Flow | -259,173 | -201,613 | -136,432 | -94,691 | -263,211 |
| Capital Expenditure | -8,843 | -6,819 | -5,989 | -3,721 | -16,750 |
| Free Cash Flow | -268,016 | -208,432 | -142,421 | -98,412 | -279,961 |